Cell Biotech Co Ltd
KOSDAQ:049960
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cell Biotech Co Ltd
KOSDAQ:049960
|
KR |
|
C
|
Centamin PLC
TSX:CEE
|
JE |
|
E
|
Eurosnack SA
WSE:ECK
|
PL |
|
Apiam Animal Health Ltd
ASX:AHX
|
AU |
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
KR |
|
Javelin Minerals Ltd
ASX:JAV
|
AU |
|
A
|
Armada Acquisition Corp I
NASDAQ:AACI
|
US |
|
Emak SpA
MIL:EM
|
IT |
|
C
|
Cwc Energy Services Corp
XTSX:CWC
|
CA |
|
Stradim Espace Finance SA
PAR:ALSAS
|
FR |
|
U
|
United Overseas Bank Ltd
F:UOB
|
SG |
|
RealReal Inc
NASDAQ:REAL
|
US |
|
E
|
Exxaro Resources Ltd
JSE:EXX
|
ZA |
|
Euro Sun Mining Inc
TSX:ESM
|
CA |
|
Noble Corp (Cayman Island)
NYSE:NE
|
US |
|
Aadi Bioscience Inc
NASDAQ:AADI
|
US |
|
B
|
BG T&A Co
KOSDAQ:046310
|
KR |
|
W
|
Wonik Co Ltd
KOSDAQ:032940
|
KR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Cell Biotech Co Ltd's stock price target?
Not Available
Cell Biotech Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Cell Biotech Co Ltd's Revenue forecast?
Projected CAGR
-2%
For the last 13 years the compound annual growth rate for Cell Biotech Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is -2%.
What is Cell Biotech Co Ltd's Operating Income forecast?
Projected CAGR
-5%
For the last 13 years the compound annual growth rate for Cell Biotech Co Ltd's operating income is 1%. The projected CAGR for the next 3 years is -5%.
What is Cell Biotech Co Ltd's Net Income forecast?
Projected CAGR
-23%
For the last 13 years the compound annual growth rate for Cell Biotech Co Ltd's net income is 9%. The projected CAGR for the next 3 years is -23%.
